A study aimed to compare corneal topographic and specular microscopic parameters both before and after patients received the ...
COVID-19 mRNA vaccines create enough of an immunity boost to extend survival in certain types of lung and skin cancers, an analysis of more than 1,000 patient files showed. The scientific journal ...
Heart inflammation caused by the mRNA COVID vaccines is rare. The COVID vaccines have saved millions of lives from a virus that has killed more than seven million people globally. Many safety studies ...
By Blake Brittain Jan 6 (Reuters) - Bayer's Monsanto sued COVID-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court on Tuesday for allegedly misusing its messenger RNA technology ...
Dr. Robert Malone — a member of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices ...
A new study has found that receiving messenger RNA-based COVID-19 vaccines such as those from Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) could boost the survival rates of ...
The U.S. Senate’s Permanent Subcommittee on Investigations held a crucial hearing titled "The Corruption of Science and ...
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Adam Grippin, The University of Texas MD Anderson Cancer Center and Christiano Marconi ...
Even as the acute phase of the COVID-19 pandemic fades, the world continues to wrestle with its aftermath — and nowhere is that more evident than in the enduring challenge of Long COVID. The condition ...
If promising results on a skin cancer vaccine from Moderna and Merck lead to a new launch, the Covid-19 era darling's stock could revive after a 91% fall from its peak.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results